Bliss GVS Pharma

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue195.99216.26167.06188.66172.43
Expenses170.88260.12151.17154.36152.49
EBITDA25.11-43.8615.8934.3019.94
EBIT20.81-48.2911.6229.7515.34
Profit Before Tax29.89-38.8626.4539.2020.19
Net Profit21.27-50.1119.6325.7213.85
Financial Ratios
Operating Profit Margin12.81%-20.28%9.52%18.18%11.56%
Net Profit Margin10.85%-23.17%11.75%13.63%8.03%
Earning Per Share (Diluted)2.01-0.221.822.441.31
Dividends Per ShareNANA0.50NANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI